INTERIM CONSOLIDATED BALANCE SHEETS (UNAUDITED) (USD $)	Oct. 31, 2013	Jul. 31, 2013
ASSETS
Cash and cash equivalents	$ 1,034,194	$ 1,708,954
Other current assets	108,503	98,315
Total Current Assets	1,142,697	1,807,269
Property and Equipment, Net	19,414	85,406
Assets Held for Investment, Net		640,772
Patents, Net	2,236,073	2,319,416
TOTAL ASSETS	3,398,184	4,852,863
LIABILITIES AND STOCKHOLDERS' (DEFICIENCY)/EQUITY
Accounts payable and accrued expenses (Note 5)	7,523,149	7,661,234
Deferred revenue	223,859	224,843
Current maturities of long-term debt (Note 11)		617,665
Total Current Liabilities	7,747,008	8,503,742
Derivative Warrant Liability (Note 10)	4,137,592	5,234,293
Derivative Additional Investment Rights Liability (Note 10)	427,732	1,256,160
Total Liabilities	12,312,332	14,994,195
Stockholders' Deficiency (Note 9):
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 1,500,000,000 shares at October 31, 2013 and July 31, 2013; 611,314,230 and 580,329,160 issued and outstanding at October 31, 2013 and July 31, 2013, respectively	611,314	580,329
Additional paid-in capital	357,066,240	356,401,812
Deficit accumulated during the development stage	(367,358,482)	(367,888,576)
Accumulated other comprehensive income	766,780	765,103
Total Stockholders' Deficiency	(8,914,148)	(10,141,332)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	3,398,184	4,852,863
Series A Convertible Preferred Stock
Stockholders' Deficiency (Note 9):
9% Convertible Preferred Stock
Series B Convertible Preferred Stock
Stockholders' Deficiency (Note 9):
9% Convertible Preferred Stock
Series C Convertible Preferred Stock
Stockholders' Deficiency (Note 9):
9% Convertible Preferred Stock
Series D Convertible Preferred Stock
Stockholders' Deficiency (Note 9):
9% Convertible Preferred Stock
Series E Convertible Preferred Stock
Stockholders' Deficiency (Note 9):
9% Convertible Preferred Stock